PMID- 24196392 OWN - NLM STAT- MEDLINE DCOM- 20140527 LR - 20161125 IS - 1462-0332 (Electronic) IS - 1462-0324 (Linking) VI - 53 IP - 2 DP - 2014 Feb TI - TACE-dependent amphiregulin release is induced by IL-1beta and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis. PG - 260-9 LID - 10.1093/rheumatology/ket350 [doi] AB - OBJECTIVES: The aims of this study were to investigate the expression of amphiregulin (AREG) and TNF-alpha-converting enzyme (TACE) in fibroblast-like synoviocytes from humans with RA (FLS-RA) when stimulated with proinflammatory cytokines and to explore whether AREG plays a role in RA. METHODS: The effects of cytokines on the expression of AREG and TACE in FLS-RA were measured by quantitative RT-PCR and western blotting. Blockade of IL-1beta-mediated pathways was used to verify the involvement of intracellular signal pathways in the induction of AREG and TACE. TAPI-1 and TACE short hairpin RNA (shRNA) infection were used to identify the role of TACE in IL-1beta-induced AREG secretion and shedding. AREG-induced production of MMP-1 and cadherin-11 in FLS-RA were measured by ELISA or western blotting. The effect of AREG on FLS-RA invasion was examined using a Transwell invasion assay. RESULTS: IL-1beta, but not other tested cytokines, increased the expressions of AREG mRNA and protein in a dose-responsive and time-dependent manner in FLS-RA. IL-1beta induced AREG expression via p38 MAPK, NF-kappaB, JNK and ERK1/2 signalling pathways and induced TACE expression via PI3K, p38MAPK and NF-kappaB signalling pathways in FLS-RA. TACE mediated AREG secretion and shedding. EGFR (ErbB1) and Her-2 (ErbB2) were expressed in FLS-RA, and AREG increased MMP-1 and cadherin-11 expression in FLS-RA. AREG promoted the FLS-RA invasion ability. CONCLUSION: AREG and TACE expression were up-regulated by IL-1beta and their activations on FLS-RA lead to the matrix degradation by inducing MMP-1 and cadherin-11 production. TACE activity is necessary for IL-1beta-induced AREG release. Our results demonstrate that IL-1beta-induced AREG release may be involved in the pathogenesis of RA. FAU - Liu, Fei-Lan AU - Liu FL AD - Rheumatology/Immunology/Allergy, Tri-Service General Hospital, 325 Cheng-Kung Road, Section 2, Neihu 114, Taipei, Taiwan, Republic of China. ming0503@ms3.hinet.net. FAU - Wu, Cheng-Chi AU - Wu CC FAU - Chang, Deh-Ming AU - Chang DM LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131106 PL - England TA - Rheumatology (Oxford) JT - Rheumatology (Oxford, England) JID - 100883501 RN - 0 (AREG protein, human) RN - 0 (Amphiregulin) RN - 0 (Cadherins) RN - 0 (EGF Family of Proteins) RN - 0 (Glycoproteins) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Interleukin-1beta) RN - 0 (NF-kappa B) RN - 156621-71-5 (osteoblast cadherin) RN - EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases) RN - EC 3.4.24.- (ADAM Proteins) RN - EC 3.4.24.7 (Matrix Metalloproteinase 1) RN - EC 3.4.24.86 (ADAM17 Protein) RN - EC 3.4.24.86 (ADAM17 protein, human) SB - IM MH - ADAM Proteins/*metabolism MH - ADAM17 Protein MH - Amphiregulin MH - Arthritis, Rheumatoid/*metabolism/pathology MH - Cadherins/metabolism MH - Cell Movement/drug effects MH - Cells, Cultured MH - Dose-Response Relationship, Drug MH - EGF Family of Proteins MH - Fibroblasts/drug effects/*metabolism/pathology MH - Glycoproteins/biosynthesis/*metabolism MH - Humans MH - Intercellular Signaling Peptides and Proteins/biosynthesis/*metabolism MH - Interleukin-1beta/*pharmacology MH - MAP Kinase Signaling System/physiology MH - Matrix Metalloproteinase 1/metabolism MH - NF-kappa B/metabolism MH - Synovial Membrane/drug effects/*metabolism/pathology MH - Time Factors MH - p38 Mitogen-Activated Protein Kinases/metabolism OTO - NOTNLM OT - IL-1beta OT - amphiregulin OT - fibroblast-like synoviocyte OT - rheumatoid arthritis EDAT- 2013/11/08 06:00 MHDA- 2014/05/28 06:00 CRDT- 2013/11/08 06:00 PHST- 2013/11/08 06:00 [entrez] PHST- 2013/11/08 06:00 [pubmed] PHST- 2014/05/28 06:00 [medline] AID - ket350 [pii] AID - 10.1093/rheumatology/ket350 [doi] PST - ppublish SO - Rheumatology (Oxford). 2014 Feb;53(2):260-9. doi: 10.1093/rheumatology/ket350. Epub 2013 Nov 6.